Correlation Between Molecular Partners and IQVIA Holdings

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Molecular Partners and IQVIA Holdings at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Molecular Partners and IQVIA Holdings into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Molecular Partners AG and IQVIA Holdings, you can compare the effects of market volatilities on Molecular Partners and IQVIA Holdings and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Molecular Partners with a short position of IQVIA Holdings. Check out your portfolio center. Please also check ongoing floating volatility patterns of Molecular Partners and IQVIA Holdings.

Diversification Opportunities for Molecular Partners and IQVIA Holdings

-0.42
  Correlation Coefficient

Very good diversification

The 3 months correlation between Molecular and IQVIA is -0.42. Overlapping area represents the amount of risk that can be diversified away by holding Molecular Partners AG and IQVIA Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on IQVIA Holdings and Molecular Partners is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Molecular Partners AG are associated (or correlated) with IQVIA Holdings. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of IQVIA Holdings has no effect on the direction of Molecular Partners i.e., Molecular Partners and IQVIA Holdings go up and down completely randomly.

Pair Corralation between Molecular Partners and IQVIA Holdings

Given the investment horizon of 90 days Molecular Partners is expected to generate 2.28 times less return on investment than IQVIA Holdings. In addition to that, Molecular Partners is 1.89 times more volatile than IQVIA Holdings. It trades about 0.02 of its total potential returns per unit of risk. IQVIA Holdings is currently generating about 0.09 per unit of volatility. If you would invest  19,438  in IQVIA Holdings on September 21, 2024 and sell it today you would earn a total of  542.00  from holding IQVIA Holdings or generate 2.79% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Molecular Partners AG  vs.  IQVIA Holdings

 Performance 
       Timeline  
Molecular Partners 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Molecular Partners AG are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of very uncertain essential indicators, Molecular Partners displayed solid returns over the last few months and may actually be approaching a breakup point.
IQVIA Holdings 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days IQVIA Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain fairly stable which may send shares a bit higher in January 2025. The latest fuss may also be a sign of long-term up-swing for the venture sophisticated investors.

Molecular Partners and IQVIA Holdings Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Molecular Partners and IQVIA Holdings

The main advantage of trading using opposite Molecular Partners and IQVIA Holdings positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Molecular Partners position performs unexpectedly, IQVIA Holdings can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in IQVIA Holdings will offset losses from the drop in IQVIA Holdings' long position.
The idea behind Molecular Partners AG and IQVIA Holdings pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.

Other Complementary Tools

Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account